Open access · CC-BY
via OpenAlex
Precision aging. Human lifespan has intrinsic limits but measurable outcomes
Aging Pathobiology and Therapeutics · 2021
Abstract
A recent article by Pyrkov et al [1] suggests that progressive loss of physical resilience to aging coincides with an absolute limit of human lifespan in the range of 120 to 150 years. Furthermore, the authors conclude that end of life is an intrinsic biological property independent of internal or external stress factors
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.31491/apt.2021.06.061
- Canonical
- link ↗
- Fetched
- 2026-10-12 MST
Cite this
APA
Ladiges, W. (2021). Precision aging. Human lifespan has intrinsic limits but measurable outcomes. <em>Aging Pathobiology and Therapeutics</em>. https://doi.org/10.31491/apt.2021.06.061
Vancouver
Ladiges W. Precision aging. Human lifespan has intrinsic limits but measurable outcomes. Aging Pathobiology and Therapeutics. 2021. doi:10.31491/apt.2021.06.061.
BibTeX
@article{warren2021Precis,
title = {Precision aging. Human lifespan has intrinsic limits but measurable outcomes},
author = {Warren Ladiges},
journal = {Aging Pathobiology and Therapeutics},
year = {2021},
doi = {10.31491/apt.2021.06.061},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
bioRxiv (Cold Spring Harbor Laboratory) 2022
Preprint · CC-BY
SIRT3 deficiency decreases oxidative-metabolism capacity but increases lifespan under caloric restriction
Aging Cell 2022
Open access · CC-BY
SIRT3 deficiency decreases oxidative metabolism capacity but increases lifespan in male mice under caloric restriction
Bioimpacts 2017
Open access · CC-BY
Debate on human aging and lifespan
Frontiers in Aging 2025
Open access · CC-BY
The lifespan-extending MEK1 inhibitor trametinib promotes regulation of de novo lipogenesis enzymes by chaperone-mediated autophagy
Frontiers in aging 2025
Open access · OA
The lifespan-extending MEK1 inhibitor trametinib promotes regulation of de novo lipogenesis enzymes by chaperone-mediated autophagy.
The journal of nutrition health & aging 2022
Open access · CC-BY